{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T20:35:10Z","timestamp":1764102910073},"reference-count":46,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","psychosomaticsjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychosomatics"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.psym.2018.01.006","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T13:58:06Z","timestamp":1517407086000},"page":"472-480","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Associations of Physical and Psychologic Symptom Burden in Patients With Philadelphia Chromosome-Negative Myeloproliferative Neoplasms"],"prefix":"10.1016","volume":"59","author":[{"given":"Daniel C.","family":"McFarland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly M.","family":"Shaffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Polizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Mascarenhas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Kremyanskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimmie","family":"Holland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.psym.2018.01.006_bib1","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood-2011-01-328955","article-title":"The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): international prospective validation and reliability trial in 402 patients","volume":"118","author":"Scherber","year":"2011","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.psym.2018.01.006_bib2","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.clinthera.2014.02.016","article-title":"Use of the functional assessment of cancer therapy\u2014anemia in persons with myeloproliferative neoplasm-associated myelofibrosis and anemia","volume":"36","author":"Tefferi","year":"2014","journal-title":"Clin Ther"},{"issue":"1","key":"10.1016\/j.psym.2018.01.006_bib3","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/cncr.22365","article-title":"The burden of fatigue and quality of life in myeloproliferative disorders (MPDs): an international Internet-based survey of 1179 MPD patients","volume":"109","author":"Mesa","year":"2007","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.psym.2018.01.006_bib4","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.6004\/jnccn.2016.0168","article-title":"Psychological symptoms among patients with BCR-ABL-negative myeloproliferative neoplasms","volume":"14","author":"McFarland","year":"2016","journal-title":"J Natl Compr Canc Netw"},{"issue":"4","key":"10.1016\/j.psym.2018.01.006_bib5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/bmjspcare-2012-000380","article-title":"The relationship between depression and physical symptom burden in advanced cancer","volume":"5","author":"Fitzgerald","year":"2015","journal-title":"BMJ Support Palliat Care"},{"issue":"3","key":"10.1016\/j.psym.2018.01.006_bib6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000362816","article-title":"The impact of symptom burden on patient quality of life in chronic myeloid leukemia","volume":"87","author":"Cella","year":"2014","journal-title":"Oncology"},{"issue":"1","key":"10.1016\/j.psym.2018.01.006_bib7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/jamaoncol.2015.89","article-title":"Myeloproliferative neoplasms: a contemporary review","volume":"1","author":"Tefferi","year":"2015","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.psym.2018.01.006_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00277-007-0403-6","article-title":"The diagnosis of BCR\/ABL-negative chronic myeloproliferative diseases (CMPD): a comprehensive approach based on morphology, cytogenetics, and molecular markers","volume":"87","author":"Haferlach","year":"2008","journal-title":"Ann Hematol"},{"issue":"3","key":"10.1016\/j.psym.2018.01.006_bib9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3322\/caac.20009","article-title":"Advances in understanding and management of myeloproliferative neoplasms","volume":"59","author":"Vannucchi","year":"2009","journal-title":"CA Cancer J Clin"},{"issue":"33","key":"10.1016\/j.psym.2018.01.006_bib10","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1200\/JCO.2012.42.3863","article-title":"Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs","volume":"30","author":"Emanuel","year":"2012","journal-title":"J Clin Oncol"},{"issue":"29","key":"10.1016\/j.psym.2018.01.006_bib12","doi-asserted-by":"crossref","first-page":"4670","DOI":"10.1200\/JCO.2006.10.0438","article-title":"Pooled results from 38 analyses of the accuracy of distress thermometer and other ultra-short methods of detecting cancer-related mood disorders","volume":"25","author":"Mitchell","year":"2007","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.psym.2018.01.006_bib13","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/cncr.23622","article-title":"Screening and referral for psychosocial distress in oncologic practice: use of the Distress Thermometer","volume":"113","author":"Tuinman","year":"2008","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.psym.2018.01.006_bib14","doi-asserted-by":"crossref","first-page":"220","DOI":"10.12968\/bjon.2011.20.4.220","article-title":"The clinical utility of the distress thermometer: a review","volume":"20","author":"Snowden","year":"2011","journal-title":"Br J Nurs"},{"issue":"5","key":"10.1016\/j.psym.2018.01.006_bib15","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s11912-015-0447-z","article-title":"The five steps of comprehensive psychosocial distress screening","volume":"17","author":"Lazenby","year":"2015","journal-title":"Curr Oncol Rep"},{"issue":"3","key":"10.1016\/j.psym.2018.01.006_bib16","doi-asserted-by":"crossref","first-page":"e413","DOI":"10.1200\/JOP.2014.002816","article-title":"Supporting commission on cancer-mandated psychosocial distress screening with implementation strategies","volume":"11","author":"Lazenby","year":"2015","journal-title":"J Oncol Pract"},{"issue":"2","key":"10.1016\/j.psym.2018.01.006_bib17","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.6004\/jnccn.2017.7017","article-title":"The prevalence of physical problems detected the Distress Thermometer and Problem List in patients with myeloproliferative neoplasms","volume":"15","author":"McFarland DC","year":"2017","journal-title":"J Natl Compr Canc Netw"},{"issue":"17","key":"10.1016\/j.psym.2018.01.006_bib18","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1200\/JCO.2013.53.4495","article-title":"Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical oncology clinical practice guideline adaptation","volume":"32","author":"Bower","year":"2014","journal-title":"J Clin Oncol"},{"issue":"19","key":"10.1016\/j.psym.2018.01.006_bib19","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1002\/cncr.28750","article-title":"Recommendations for the implementation of distress screening programs in cancer centers: report from the American Psychosocial Oncology Society (APOS), Association of Oncology Social Work (AOSW), and Oncology Nursing Society (ONS) joint task force","volume":"120","author":"Pirl","year":"2014","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.psym.2018.01.006_bib20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0022-3999(01)00296-3","article-title":"The validity of the Hospital Anxiety and Depression Scale. An updated literature review","volume":"52","author":"Bjelland","year":"2002","journal-title":"J Psychosom Res"},{"issue":"6","key":"10.1016\/j.psym.2018.01.006_bib21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.psym.2018.01.006_bib22","series-title":"The Regression Analysis of Count Data. 2nd ed.","author":"Cameron","year":"2013"},{"issue":"4","key":"10.1016\/j.psym.2018.01.006_bib23","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1200\/JCO.1998.16.4.1594","article-title":"Oncologists\u2032 recognition of depression in their patients with cancer","volume":"16","author":"Passik","year":"1998","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.psym.2018.01.006_bib24","first-page":"593","article-title":"Nurses\u2032 recognition of depression in their patients with cancer","volume":"26","author":"McDonald","year":"1999","journal-title":"Oncol Nurs Forum"},{"issue":"8","key":"10.1016\/j.psym.2018.01.006_bib25","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1470-2045(13)70244-4","article-title":"Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis","volume":"14","author":"Mitchell","year":"2013","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.psym.2018.01.006_bib26","first-page":"999","article-title":"The management of psychological issues in oncology","volume":"14","author":"McFarland","year":"2016","journal-title":"Clin Adv Hematol Oncol"},{"issue":"22","key":"10.1016\/j.psym.2018.01.006_bib27","doi-asserted-by":"crossref","first-page":"5349","DOI":"10.1002\/cncr.24561","article-title":"Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis","volume":"115","author":"Satin","year":"2009","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.psym.2018.01.006_bib28","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s11764-013-0286-6","article-title":"Depressive symptoms are a risk factor for all-cause mortality: results from a prospective population-based study among 3,080 cancer survivors from the PROFILES registry","volume":"7","author":"Mols","year":"2013","journal-title":"J Cancer Surviv"},{"issue":"4","key":"10.1016\/j.psym.2018.01.006_bib29","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1200\/JCO.2010.28.4455","article-title":"Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: a secondary analysis","volume":"29","author":"Giese-Davis","year":"2011","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.psym.2018.01.006_bib30","first-page":"12","article-title":"The link between depression and physical symptoms","volume":"6","author":"Trivedi","year":"2004","journal-title":"Prim Care Companion J Clin Psychiatry"},{"issue":"5","key":"10.1016\/j.psym.2018.01.006_bib31","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s00520-014-2471-1","article-title":"An analysis of the distress thermometer problem list and distress in patients with cancer","volume":"23","author":"VanHoose","year":"2015","journal-title":"Support Care Cancer"},{"issue":"11","key":"10.1016\/j.psym.2018.01.006_bib32","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1007\/s00520-016-3294-z","article-title":"Which items on the distress thermometer problem list are the most distressing?","volume":"24","author":"Clover","year":"2016","journal-title":"Support Care Cancer"},{"issue":"7 Suppl","key":"10.1016\/j.psym.2018.01.006_bib33","first-page":"S99","article-title":"Is symptom burden a predictor of anxiety and depression in patients with cancer about to commence chemotherapy?","volume":"190","author":"Breen","year":"2009","journal-title":"Med J Aust"},{"issue":"3","key":"10.1016\/j.psym.2018.01.006_bib34","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1176\/appi.psy.44.3.244","article-title":"Somatic symptoms for diagnosing major depression in cancer patients","volume":"44","author":"Akechi","year":"2003","journal-title":"Psychosomatics"},{"issue":"32","key":"10.1016\/j.psym.2018.01.006_bib35","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/jncimonographs\/lgh019","article-title":"Barriers to the treatment of depression in cancer patients","author":"Greenberg","year":"2004","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"1","key":"10.1016\/j.psym.2018.01.006_bib36","first-page":"91","article-title":"The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and select comorbid medical conditions","volume":"24","author":"Ramasubbu","year":"2012","journal-title":"Ann Clin Psychiatry"},{"issue":"3","key":"10.1016\/j.psym.2018.01.006_bib37","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jpainsymman.2014.07.008","article-title":"A systematic review of the demoralization syndrome in individuals with progressive disease and cancer: a decade of research","volume":"49","author":"Robinson","year":"2015","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.psym.2018.01.006_bib38","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neuroscience.2013.04.060","article-title":"Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications","volume":"246","author":"Felger","year":"2013","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.psym.2018.01.006_bib39","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0889-1591(03)00078-3","article-title":"Circadian disruption in cancer: a neuroendocrine-immune pathway from stress to disease?","volume":"17","author":"Sephton","year":"2003","journal-title":"Brain Behav Immun"},{"issue":"4","key":"10.1016\/j.psym.2018.01.006_bib40","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jsmc.2015.07.004","article-title":"Circadian disruption in psychiatric disorders","volume":"10","author":"Jones","year":"2015","journal-title":"Sleep Med Clin"},{"key":"10.1016\/j.psym.2018.01.006_bib41","doi-asserted-by":"crossref","first-page":"284706","DOI":"10.1155\/2015\/284706","article-title":"Impact of Inflammation on myeloproliferative neoplasm symptom development","volume":"2015","author":"Geyer","year":"2015","journal-title":"Mediators Inflamm"},{"issue":"10","key":"10.1016\/j.psym.2018.01.006_bib42","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1200\/JCO.2010.32.9490","article-title":"Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study","volume":"29","author":"Tefferi","year":"2011","journal-title":"J Clin Oncol"},{"issue":"24","key":"10.1016\/j.psym.2018.01.006_bib43","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.1182\/blood-2011-04-348144","article-title":"TNFalpha facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms","volume":"118","author":"Fleischman","year":"2011","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.psym.2018.01.006_bib44","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.bbi.2007.01.010","article-title":"Depressive disorders and immunity: 20 years of progress and discovery","volume":"21","author":"Irwin","year":"2007","journal-title":"Brain Behav Immun"},{"issue":"1","key":"10.1016\/j.psym.2018.01.006_bib45","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.it.2005.11.006","article-title":"Cytokines sing the blues: inflammation and the pathogenesis of depression","volume":"27","author":"Raison","year":"2006","journal-title":"Trends Immunol"},{"key":"10.1016\/j.psym.2018.01.006_bib46","doi-asserted-by":"crossref","first-page":"670580","DOI":"10.1155\/2015\/670580","article-title":"Circulating cytokine levels as markers of inflammation in Philadelphia negative myeloproliferative neoplasms: diagnostic and prognostic interest","volume":"2015","author":"Mondet","year":"2015","journal-title":"Mediators Inflamm."},{"issue":"1","key":"10.1016\/j.psym.2018.01.006_bib47","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.psym.2016.10.002","article-title":"Psychological manifestations of early childhood adversity in the context of chronic hematologic malignancy","volume":"58","author":"McFarland","year":"2017","journal-title":"Psychosomatics"}],"container-title":["Psychosomatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033318218300380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033318218300380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T01:57:31Z","timestamp":1540432651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033318218300380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0033318218300380"],"URL":"https:\/\/doi.org\/10.1016\/j.psym.2018.01.006","relation":{},"ISSN":["0033-3182"],"issn-type":[{"value":"0033-3182","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations of Physical and Psychologic Symptom Burden in Patients With Philadelphia Chromosome-Negative Myeloproliferative Neoplasms","name":"articletitle","label":"Article Title"},{"value":"Psychosomatics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psym.2018.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Academy of Psychosomatic Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}